Endometrial osseous metaplasia is a rare pathological condition with mature bone in the endometrium and can be a cause for menorrhagia and infertility as bone in the endometrium acts like intrauterine contraceptive device. We report one such case with brief review of literature in a 28-year-old woman presenting with history of menorrhagia.
Endometrial metaplasias are of two types, epithelial metaplasia which is commonly encountered and stromal metaplasia, unusually seen. This includes formation within endometrial stroma, islands of smooth muscle, cartilage, and bone. Endometrial stromal (cartilaginous) metaplasias are conditions frequently overlooked and misdiagnosed. Hence, a careful clinical and histopathological examination is required to avoid the misinterpretation of non-tumor cartilaginous foci as a component of malignant neoplasm. Herein, we report a rare case of endometrial cartilaginous metaplasia which was an incidental finding in a 38-year-old female with third degree uterovaginal prolapse.
Epithelial carcinoma accounts for more than 95% of ovarian malignancy. Approximately 15% of all ovarian tumours are mucinous. Approximately 80% of the mucinous tumour are benign, 10% are borderline and 10% are invasive carcinomas. Hence bilateral invasive mucinous carcinoma is a rare type of tumour with low incidence. In our case, a 37 years old woman presented with irregular menses, oligomenorrhea, pain in abdomen and abdominal distension. Radiological studies suggested endometriotic cysts however on histopathological examination, it revealed mucinous cystadenocarcinoma in both ovary. Thus histopathology is gold standard for definitive diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.